社会実装看護創成研究センター

Ryoko Murayama

  (村山 陵子)

Profile Information

Affiliation
Professor, Research Center for Implementation Nursing Science Initiative, Reseach Promotion Headquarters, Fujita Health University
Degree
Doctor(Eng)(Nihon University)

J-GLOBAL ID
201101039091532212
researchmap Member ID
1000296219

Papers

 111
  • Yuka Sano, Junko Sugama, Hiroe Koyanagi, Ryoko Murayama, Takuma Ishihara, Masushi Kohta, Keiko Mano
    Fujita medical journal, 10(4) 98-105, Nov, 2024  
    OBJECTIVES: We aimed to determine (1) the prevalence of constipation among inpatients, (2) the prevalence and symptoms of difficult defecation among constipated inpatients, and (3) the factors associated with constipation. METHODS: We performed a retrospective cohort study over a single day at one university hospital. We analyzed the nursing records for inpatients who had been hospitalized for at least 3 days. The survey items included the symptoms associated with defecation difficulty and nutritional intake. The symptoms of difficult defecation were defined as (1) fewer than three spontaneous bowel movements per week; (2) lumpy or hard stools (Bristol stool form scale types 1-2); (3) straining during defecation; and (4) the sensation of incomplete evacuation during defecation, based on the Roma-IV diagnostic criteria. Constipation was defined as the presence of two or more symptoms of defecation difficulty. Univariate and multivariate analyses were performed to determine the constipation status of the patients. RESULTS: The prevalence of constipation in the university hospital was 12.2%, and the department with the highest prevalence of difficulty with defecation was the Psychiatry Department (64.1%). Of the patients with constipation, 36.8% exhibited symptoms of defecation difficulty other than low frequency of defecation. The factor that was significantly associated with constipation after admission was pre-admission constipation (odds ratio=8.92, p<0.01). CONCLUSIONS: Subjective assessment has limitations for the accurate determination of constipation status. In addition, patients with a history of constipation before admission require early interventions to aid defecation following their admission.
  • 村山 陵子, 芦田 沙矢香, 南谷 真理子, 松崎 政代, 吉田 美香子, 春名 めぐみ
    日本助産学会誌, 37(3) 243-251, Dec, 2023  
  • Mari Abe-Doi, Ryoko Murayama, Kojiro Morita, Gojiro Nakagami, Hiromi Sanada
    Asian Nursing Research, 17(5) 269-275, Dec, 2023  
  • Ryoko Murayama, Mari Abe-Doi, Yosuke Masamoto, Kosuke Kashiwabara, Chieko Komiyama, Hiromi Sanada, Mineo Kurokawa
    Drug discoveries & therapeutics, 17(1) 52-59, Mar 11, 2023  
    Intravenous infusion using a peripheral intravenous catheter (PIVC) is often complicated by catheter failure (CF). We hypothesized that catheterization of an upper arm vein instead of a forearm vein may help prevent CF. This study was designed to compare the incidence of CF in patients receiving hyper-stimulant drugs when catheters are placed in the forearm using short PIVCs (SPCs) with that when catheters are placed in the upper arm using the new long PIVCs. Patients admitted to a university hospital in Tokyo, Japan were enrolled in this study and were assigned to the SPC or the new long PIVC group. The primary outcome was the incidence of CF until 7 days. The secondary outcomes were the number of CFs per 1,000 days, the duration of the indwelling catheter, and the presence of thrombi and subcutaneous edema. Forty-seven patients were analyzed (median age, 67.0 years). The incidence of CF was 0% in the new long PIVCs and 32.0% (8 catheters) in the SPCs (p = 0.007), and the number of CF per 1,000 days was 0/1,000 and 81.7/1,000 days, respectively (p = 0.001). A significant difference in the duration of the indwelling catheter until CF occurrence was observed between the two groups (p = 0.004). Thrombi and subcutaneous edema were observed more frequently in the SPC group (p < 0.001). Catheterization of an upper arm vein using the new long PIVC to administer a hyper-stimulant drug might reduce CF compared with catheterization of a forearm vein using SPC.

Misc.

 73
  • 高橋聡明, 新谷結衣, 村山陵子, 村山陵子, 野口博史, 阿部麻里, KOUDOUNAS Sofoklis, 仲上豪二朗, 仲上豪二朗, 森武俊, 真田弘美, 真田弘美
    日本創傷・オストミー・失禁管理学会誌(Web), 25(3), 2021  
  • 村山陵子, 村山陵子, 阿部麻里, 木暮貴政, 高橋聡明, 菅野智穂, 石垣真理, 真田弘美, 真田弘美
    看護理工学会誌(Web), 8, 2021  
  • 阿部麻里, 大江真琴, 池田真理, 村山陵子, 村山陵子, 小見山智恵子, 真田弘美, 真田弘美
    看護理工学会誌(Web), 8, 2021  
  • Mari Abe-Doi, Ryoko Murayama, Chieko Komiyama, Hiromi Sanada
    Japan journal of nursing science : JJNS, e12329, Feb 9, 2020  
    AIMS: Following chemotherapy, induration may occur. This study was conducted to survey induration incidence and risk factors, and investigation for actual condition of induration. METHODS: A cohort study was conducted for survey of incidence and risk factors, and a cross-sectional observation study was conducted to examine actual condition of induration. The sites of chemotherapy administration were recorded, and these were observed on the next treatment day. Clinical nurses judged the presence or absence of induration by palpation. The sites were observed using ultrasonography. To investigate the risk factors associated with the induration, logistic regression analysis was performed using independent variables based on univariate analysis or previous reports. RESULTS: In total, 69 patients were analyzed. The induration incidence was 17.4%, and three abnormal conditions were confirmed: subcutaneous edema, thrombosis, and thickening of the vessel wall. Breast cancer, non-vesicant drug, vein diameter, and fosaprepitant use were included in the logistic regression model. Breast cancer: odds ratio (OR) 9.25; 95 CI 1.91.-44.71; non-vesicant drug: OR 1.37; 95 CI 0.13-14.95; vein diameter: OR 0.40; 95% CI 0.16-0.97; fosaprepitant use: OR 0.16; 95% CI, 0.18-10.32. CONCLUSIONS: The induration incidence was 17.4%. Risk factors for induration following chemotherapy administration were breast cancer and smaller vein diameter. Abnormal cases of subcutaneous tissue were confirmed, including subcutaneous edema, thrombosis, and thickening of the vessel wall. Induration may be prevented by selecting larger diameter vessels using ultrasonography when catheterizing for chemotherapy.
  • Chiho Kanno, Ryoko Murayama, Mari Abe-Doi, Toshiaki Takahashi, Yui Shintani, Junko Nogami, Chieko Komiyama, Hiromi Sanada
    Drug discoveries & therapeutics, 14(1) 27-34, 2020  
    Up to 50% peripheral intravenous catheters (PIVs) are removed prematurely because of failures. Catheter failure (CF) leads to replacement and is a great concern for patients and medical staff. It is known that visualization of catheters and vessels with ultrasonography (US) during placement prevents CF. However, US is not a common technique for general nurses. In order to standardize US-assisted PIV placement techniques, an algorithm is needed. This study aimed to develop an algorithm using US-assisted PIV placement to reduce CF rate. Furthermore, to evaluate the effectiveness of the algorithm, CF rates were compared before and after intervention. A pretest-posttest study was performed. The intervention was PIV placement by 23 nurses undergoing training sessions for the algorithm. Intention to treat, per protocol analyses were applied. Logistic regression analysis was used for factor analysis. The CF rate in the pre-intervention group 35.2% (19/54) did not significantly differ from post-intervention group 33.6% (48/143) (p = 0.831), yet significantly differ from complete algorithm-use group 8.7% (2/23; p = 0.017). In factor analysis, compliance to the algorithm was significantly correlated with CF (p = 0.032). The compliance rate was low 16.1% (23/143). Algorithm compliance reduced CF by confirming appropriate catheter tip position from the insertion to the securement phase. This algorithm effectively reduced CF, however, the compliance rate was unacceptable. In order to increase the compliance rate, modified algorithm and new visualizing technology is required.

Books and Other Publications

 10

Professional Memberships

 8

Research Projects

 28